Skip to product information
1 of 1

FDA Drug Approval, N017381, SILVADENE

FDA Drug Approval, N017381, SILVADENE

Regular price $404.41 USD
Regular price Sale price $404.41 USD
Sale Sold out

NDA: 017381
Company: KING PHARMS LLC
Drug Name: SILVADENE
Active Ingredients: SILVER SULFADIAZINE
Strength: 1%
Dosage Form/Route: CREAM;TOPICAL
Action Date: 11/26/1973
Marketing Status: Prescription
Submission Classification: Type 2 - New Active Ingredient

118 pages including Approval Letter, Final Printed Label, Medical Officer's Review, Chemist's Review, Pharmacologist's Review, Microbiologist's Review, Supplements, SBA 

View full details
FOIA Pro

This drug has a lot more FDA history than one product page can show

FOIA Pro gives you full-text search across 70,000+ FDA FOIA records, from 2020 through today, plus a monthly monitor tracking new requests as they close.
  • Full-text search across every FDA FOIA log since 2020
  • Warning letters, approval records, and correspondence in one place
  • Monthly FDA FOIA Monitor newsletter, included
  • Cancel anytime, monthly or annual billing
Get FOIA Pro
Live search · FOIA database
Searching related FDA records…
ClosedTypeSubjectOutcome